CELLRIGHT TECHNOLOGIES
CellRight Technologies operates as a biotechnology company. The Company specializes in regenerative medicine and develops osteoinductive and wound care scaffolds to improve healing opportunities of defects created by trauma and disease. CellRight Technologies serves customers in the State of Texas. CellRight Technologies is the industry leader of osteoinductive matrices and is committed to providing clinicians and their patients with verified osteoinductive implants known to positively impact patient and fusion outcomes. In-vivo and in-vitro testing to verify osteoinductivity is performed post-sterilization by an independent testing laboratory using validated osteoinductivity test methods.
CELLRIGHT TECHNOLOGIES
Industry:
Biotechnology
Founded:
2011-01-01
Address:
Universal City, Texas, United States
Country:
United States
Website Url:
http://www.cellrighttechnologies.com
Status:
Active
Contact:
1(210)659-9353
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Cyclenium Pharma
Cyclenium Pharma is an emerging biotechnology company.
Official Site Inspections
http://www.cellrighttechnologies.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "CellRight Technologies" on Search Engine
Home - Tissue Regenix
CellRight Technologies. Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.See details»
Tissue Regenix to buy CellRight Technologies - NS Medical Devices
Jul 24, 2017 The combined group provides CellRight Technologies with the infrastructure of a larger, multi-national organization and a platform to enter new geographies. CellRight Technologies’ human tissue-based products, including Matrix OI, will expand the current Tissue Regenix portfolio, which includes DermaPure® for wound care applications.See details»
Our story - Tissue Regenix
In 2017 Tissue Regenix also completed the successful acquisition of CellRight Technologies, based in San Antonio, Texas. US $81BN Expected value of the Global Regenerative Medicine Market by 2023 1See details»
Tissue Regenix Announces Proposed Acquisition of CellRight …
CellRight Technologies is the industry leader of osteoinductive matrices and is committed to providing clinicians and their patients with verified osteoinductive implants known to positively impact patient and fusion outcomes.See details»
Tissue Regenix Completes Acquisition of CellRight …
In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and...See details»
Tissue Regenix Completes Acquisition of CellRight Technologies
Aug 9, 2017 Tissue Regenix (TRX) completed its acquisition of CellRight Technologies. The purchase price was previously noted as US $30.0MM. The transaction more than doubles TRX's U.S. sales and pairs complementary platforms of soft tissue regeneration with CellRight's regenerative osteoconductive bone scaffolds.See details»
Tissue Regenix acquires CellRight Technologies in $30M deal: 6 …
Aug 10, 2017 Tissue Regenix acquired CellRight Technologies today, according to MASS DEVICE. Here are six things to know: 1. The acquisition, which closed today, totaled $30 million. 2. Tissue Regenix hopes the acquisition will boost its U.S. presence by more than doubling its sales in the area. 3.See details»
Tissue Regenix Completes Acquisition of CellRight …
Aug 9, 2017 Leveraging the capabilities of CellRight Technologies’ existing tissue bank in San Antonio, Texas, Tissue Regenix is set to launch its OrthoPure HT, decellularized human tendon, into the U.S. …See details»
Tissue Regenix raises 40 million pounds to buy U.S. regenerative ...
Jul 21, 2017 LONDON (Reuters) - Tissue Regenix said on Friday it had raised 40 million pounds ($52 million) by selling new shares to buy CellRight Technologies, a U.S regenerative medicine company that...See details»
Overview - Tissue Regenix
CellRight Technologies ® offers patients and surgeons advanced science in its comprehensive portfolio of dental biologics. The DentalFix ™ portfolio of biologics includes traditional as well as innovative, osteoinductive verified, matrices that feature exceptional handling properties.See details»
Tissue Regenix closes $30m CellRight acquisition - MassDevice
Aug 9, 2017 Tissue Regenix (LON:TRX) said today it closed its $30 million (£23 million) acquisition of CellRight Technologies and its line of spinal surgery and orthopedic products.See details»
Initial phase of Cellright Technologies/Tissue Regenix expansion ...
In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and soft tissue scaffolds that enhance healing opportunities of defects created by trauma and disease.See details»
CellRight Technologies | International Trade Center
Jan 7, 2019 Pioneering in the cutting-edge field of biotechnology, CellRight Technologies® works on the front lines in setting the standards for their industry on a global stage, as they reflect the excellence and innovation of the San Antonio community, the state of Texas, and our Nation as a whole.See details»
Tissue Regenix Announces Proposed Acquisition of CellRight …
Jul 21, 2017 CellRight Technologies’ human tissue-based products, including Matrix OI, will expand the current Tissue Regenix portfolio, which includes DermaPure® for wound care applications.See details»
CellRight Technologies, A Subsidary of Tissue Regenix
Donate Life is a registered trademark of Donate Life America. Footer. Accreditation & Membership . Institutional Accreditation; Affiliate Partner MembershipSee details»
CellRight Technologies Careers and Employment | Indeed.com
CellRight Technologies is an industry leader of verified osteoinductive matrices and is committed to providing clinicians and their patients with differentiated implants known to positively impact patient and fusion outcomes.See details»
Home - Tissue Regenix
Regenerative medicine is an innovative and expanding field, researching the potential of tissue engineering to offer a natural recovery by triggering a response through the body’s own cells, and enable the natural regeneration of …See details»
Overview - Tissue Regenix
Orthopaedics. Overview. A regenerative approach to tissue repair and return to pre-injury activity, using 2 innovative technology platforms: dCELL®for soft tissues. BioRinse™for bone products. An acute soft tissue joint injury can significantly affect the quality of life of a previously healthy and active individual.See details»
Tissue Regenix Completes Acquisition Of CellRight Technologies
In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease.See details»
Ottawa abolishes green fund in response to scathing AG report
4 days ago According to Auditor General Karen Hogan, Sustainable Development Technology Canada (SDTC) violated its conflict of interest policies 90 times, awarded $59 million to 10 projects that were not ...See details»